Medscape Urology

Medscape Urology provides you with breaking medical news; reference on drugs, diseases, and procedures; and free CME.

[Medscape Urology @MedscapeUrology]

Delayed escalation in advanced prostate cancer compromises outcomes.

Explore the clinical rationale behind moving directly to doublet or triplet combinations to protect long-term patient survival.

Watch the clip here ➡️ https://t.co/BAnaZ16wxO

#Oncology #MedEd #CME

[Medscape Urology @MedscapeUrology]

Monotherapy is rapidly being relegated to the past.

Learn why early combination protocols are non-negotiable to delay progression to castration resistance and maximize patient survival.

Catch up on the latest data ➡️ https://t.co/BAnaZ16wxO

#Oncology #MedEd #CME

[Medscape Urology @MedscapeUrology]

Early treatment intensification is a game-changer in mHSPC.

Watch as experts explain why missing the early treatment window means patients can't make up the lost survival benefit later.

Watch the full episode ➡️ https://t.co/BAnaZ16wxO

#Oncology #MedEd #CME

[Medscape Urology @MedscapeUrology]

Starting in 1 HOUR ➡️ https://t.co/wVu86Pv1fb

mHSPC care is evolving rapidly. Join our live expert exchange with Dr. Shore, Dr. McKay, and Dr. Caulfield to explore the latest clinical data on treatment intensification and combination management.

#Oncology #Urology #CME

[Medscape Urology @MedscapeUrology]

LIVE TOMORROW: A deep dive into doublet and triplet combinations for mHSPC. ➡️ https://t.co/wVu86Pv1fb

Equip your interprofessional care team with practical tools to manage treatment intensification strategies and elevate patient care. See you there!

🗓️ May 27th
⏰ 12:30pm EST

[Medscape Urology @MedscapeUrology]

Intensifying treatment beyond ADT is critical in mHSPC.

Join our expert panel to dive into combination therapies, manage drug interactions, and get actionable insights for your practice.

🗓️ May 27th
⏰ 12:30pm EST
🔗 https://t.co/wVu86Pv1fb

[Medscape Urology @MedscapeUrology]

SAVE THE DATE 🗓️

mHSPC treatment landscape is shifting. Join Dr. Neal Shore, Dr. Rana McKay, and Sarah Caulfield, PharmD, BCOP, as they evaluate the latest evidence for emerging doublet and triplet combination strategies.

🗓️ May 27th
⏰ 12:30pm EST
🔗 https://t.co/wVu86Pv1fb

[Medscape Urology @MedscapeUrology]

Interesting - Drugs affect women and ethnicities in different ways... via @US_FDA https://t.co/yjIPPOxEML

[U.S. FDA @US_FDA]

FDA's Drug Trials Snapshots Report provides participant diversity #s in clinical trials for novel drugs approved. https://t.co/azXHOMWknw

[Eric Topol @EricTopol]

Doctor, Cure Thyself https://t.co/iekNsYa6kg on @DavidFajgenbaum's incredible story #RareDisease by @katie_thomas @NYTHealth

[Medscape @Medscape]

Medscape poll: This surgeon lied to protect a colleague. https://t.co/waoIvyizzs Would you? Read, decide, vote.

[Medscape @Medscape]

Medscape Poll: In your practice, do you spend more time on the computer than with patients? Read, decide, vote: https://t.co/Iy9PBpjLwb

[Medscape @Medscape]

Medscape Poll: Should patients take more responsibility for their outcomes? Read, decide, vote. https://t.co/99Yf5NxsRO

[Medscape @Medscape]

Medscape Poll: Would you choose your specialty again? Read, decide, vote. https://t.co/74mSP9AxhS

[Medscape Urology @MedscapeUrology]

Test for Postoperative Radiation Response in Prostate Cancer https://t.co/LNzwu6xRXQ

[Medscape Urology @MedscapeUrology]

FDA Adds New Warnings to All Testosterone Product Labels https://t.co/0dw5ONvHQF

[Medscape Urology @MedscapeUrology]

Digital Rectal Exam's Role Unclear in Prostate Cancer https://t.co/LcBKZZi47Y

[Medscape Urology @MedscapeUrology]

Final Moonshot Report: US Is 'Positioned to End Cancer' https://t.co/NYrfngU0uw

[Medscape Urology @MedscapeUrology]

Immunotherapy 'Altering the Landscape' for Bladder Cancer https://t.co/VLm2THx0g9

[Medscape Urology @MedscapeUrology]

Practice-Changing Data to Feature at ESMO 2016 https://t.co/G9sNpRUNne

[Medscape Urology @MedscapeUrology]

CDC More Cautious on Conception, Sex After Zika Exposure https://t.co/uQOXw2WhXH